[Congressional Record Volume 163, Number 6 (Tuesday, January 10, 2017)]
[Senate]
[Page S214]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 79. Mr. DURBIN (for himself and Ms. Klobuchar) submitted an 
amendment intended to be proposed by him to the concurrent resolution 
S. Con. Res. 3, setting forth the congressional budget for the United 
States Government for fiscal year 2017 and setting forth the 
appropriate budgetary levels for fiscal years 2018 through 2026; which 
was ordered to lie on the table; as follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO 
                   SUPPORTING STEADY, PREDICTABLE GROWTH FOR 
                   BIOMEDICAL RESEARCH.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution 
     for one or more bills, joint resolutions, amendments, 
     amendments between the Houses, motions, or conference reports 
     relating to supporting at least 5 percent real growth (above 
     inflation) to medical research conducted by each of the 
     National Institutes of Health, the Centers for Disease 
     Control and Prevention, the Defense Health Program, and the 
     Medical and Prosthetics Research Program of the Department of 
     Veterans Affairs by the amounts provided in such legislation 
     for those purposes, provided that such legislation would not 
     increase the deficit over either the period of the total of 
     fiscal years 2017 through 2021 or the period of the total of 
     fiscal years 2017 through 2026.
                                 ______